Home
AMGN
AMGN News

Latest Amgen Inc. (AMGN) News on March 29, 2025

2 Large-Cap Stocks with Solid Fundamentals and 1 to Turn Down

StockStory

a day ago

2 Large-Cap Stocks with Solid Fundamentals and 1 to Turn Down

Which Dow Jones Stock Is Cheaper, Amgen or Merck?

Motley Fool

a day ago

Which Dow Jones Stock Is Cheaper, Amgen or Merck?

Trump Weighs Tariffs on Pharma in Ireland. What It Means for Amgen, Gilead.

Barrons.com

2 days ago

Trump Weighs Tariffs on Pharma in Ireland. What It Means for Amgen, Gilead.

VKTX Finishes Enrolment in Mid-Stage Study on Oral Weight-Loss Drug

Zacks

2 days ago

VKTX Finishes Enrolment in Mid-Stage Study on Oral Weight-Loss Drug

How AZ and Amgen’s Tezspire respiratory data ups the ‘level of ambition’ in immunology

Pharma Voice

2 days ago

How AZ and Amgen’s Tezspire respiratory data ups the ‘level of ambition’ in immunology

Amgen (AMGN) Stock Drops Despite Market Gains: Important Facts to Note

Zacks

5 days ago

Amgen (AMGN) Stock Drops Despite Market Gains: Important Facts to Note

Is Amgen Inc. (AMGN) The Best Healthcare Dividend Stock to Invest in?

Insider Monkey

6 days ago

Is Amgen Inc. (AMGN) The Best Healthcare Dividend Stock to Invest in?

Why Amgen (AMGN) is a Top Value Stock for the Long-Term

Zacks

8 days ago

Why Amgen (AMGN) is a Top Value Stock for the Long-Term

3 of Goldman Sachs' best investing tips for currently volatile markets

Yahoo Finance

8 days ago

3 of Goldman Sachs' best investing tips for currently volatile markets

FDA Accepts RDY & ALVO's Prolia & Xgeva Biosimilar BLA for Review

Zacks

10 days ago

FDA Accepts RDY & ALVO's Prolia & Xgeva Biosimilar BLA for Review

Why the Market Dipped But Amgen (AMGN) Gained Today

Zacks

11 days ago

Why the Market Dipped But Amgen (AMGN) Gained Today

Amgen Rises Almost 22% YTD: Should You Buy, Hold or Sell the Stock?

Zacks

11 days ago

Amgen Rises Almost 22% YTD: Should You Buy, Hold or Sell the Stock?

Prediction: These 2 Stocks Will Outperform the Market Through 2030

Motley Fool

11 days ago

Prediction: These 2 Stocks Will Outperform the Market Through 2030

Amgen Inc. (AMGN): Among the Best Biotech Stocks to Buy According to Billionaires

Insider Monkey

11 days ago

Amgen Inc. (AMGN): Among the Best Biotech Stocks to Buy According to Billionaires

Amgen (AMGN) Exceeds Market Returns: Some Facts to Consider

Zacks

12 days ago

Amgen (AMGN) Exceeds Market Returns: Some Facts to Consider

AMGN Posts Upbeat Data on Uplizna From Myasthenia Gravis Study

Zacks

12 days ago

AMGN Posts Upbeat Data on Uplizna From Myasthenia Gravis Study

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

12 days ago

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It

MT Newswires

15 days ago

Regeneron Shares Fall After US Appeals Court Denies Request for Stay on Eylea Biosimilars

Amgen data ‘muddies’ outlook for Cartesian, says Oppenheimer

TipRanks

15 days ago

Amgen data ‘muddies’ outlook for Cartesian, says Oppenheimer

Amgen’s gMG therapy cuts disease symptoms at one-year mark

Clinical Trials Arena

16 days ago

Amgen’s gMG therapy cuts disease symptoms at one-year mark

Amgen (NasdaqGS:AMGN) Announces Promising MINT Trial Data For UPLIZNA In Generalized Myasthenia Gravis

Simply Wall St.

16 days ago

Amgen (NasdaqGS:AMGN) Announces Promising MINT Trial Data For UPLIZNA In Generalized Myasthenia Gravis

Is Amgen Inc. (AMGN) the Best Pharma Stock to Buy According to Hedge Funds?

Insider Monkey

16 days ago

Is Amgen Inc. (AMGN) the Best Pharma Stock to Buy According to Hedge Funds?

Amgen's Uplizna Shows Improved Symptoms In Patients With Muscle Weakness Disorder Over One Year

Benzinga

16 days ago

Amgen's Uplizna Shows Improved Symptoms In Patients With Muscle Weakness Disorder Over One Year

Exelixis (EXEL) Up 13.4% Since Last Earnings Report: Can It Continue?

Zacks

16 days ago

Exelixis (EXEL) Up 13.4% Since Last Earnings Report: Can It Continue?

MT Newswires

16 days ago

Amgen Says Phase 3 Data Support Uplizna's Efficacy in Generalized Myasthenia Gravis

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Zacks

16 days ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

UPLIZNA® (INEBILIZUMAB-CDON) SIGNIFICANTLY IMPROVES GENERALIZED MYASTHENIA GRAVIS SYMPTOMS IN ACETYLCHOLINE RECEPTOR AUTOANTIBODY-POSITIVE PATIENTS OVER 52 WEEKS

PR Newswire

16 days ago

UPLIZNA® (INEBILIZUMAB-CDON) SIGNIFICANTLY IMPROVES GENERALIZED MYASTHENIA GRAVIS SYMPTOMS IN ACETYLCHOLINE RECEPTOR AUTOANTIBODY-POSITIVE PATIENTS OVER 52 WEEKS

Amgen Inc. (AMGN): Among Dobermans of the Dow to Buy

Insider Monkey

17 days ago

Amgen Inc. (AMGN): Among Dobermans of the Dow to Buy

HALO vs. AMGN: Which Stock Is the Better Value Option?

Zacks

18 days ago

HALO vs. AMGN: Which Stock Is the Better Value Option?

Stock market sell-off: Why these stocks are in the green amid the pain

Yahoo Finance

19 days ago

Stock market sell-off: Why these stocks are in the green amid the pain

AMGN's Eczema Drug Meets Goal in Two Late-Stage Studies

Zacks

19 days ago

AMGN's Eczema Drug Meets Goal in Two Late-Stage Studies

Amgen and Kyowa Kirin’s rocatinlimab trial for atopic dermatitis meets endpoints

Clinical Trials Arena

19 days ago

Amgen and Kyowa Kirin’s rocatinlimab trial for atopic dermatitis meets endpoints

Take the Zacks Approach to Beat the Markets: NioCorp, AngloGold, Amgen in Focus

Zacks

19 days ago

Take the Zacks Approach to Beat the Markets: NioCorp, AngloGold, Amgen in Focus

3 Magnificent Growth Stocks to Buy in March

Motley Fool

21 days ago

3 Magnificent Growth Stocks to Buy in March

AMGEN AND KYOWA KIRIN PROVIDE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 IGNITE STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS

PR Newswire

21 days ago

AMGEN AND KYOWA KIRIN PROVIDE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 IGNITE STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS

Qiagen (QGEN) Down 6% Since Last Earnings Report: Can It Rebound?

Zacks

22 days ago

Qiagen (QGEN) Down 6% Since Last Earnings Report: Can It Rebound?

The Art of Valuation: Discovering Amgen Inc's Intrinsic Value

GuruFocus.com

22 days ago

The Art of Valuation: Discovering Amgen Inc's Intrinsic Value

2 Dividend Stocks to Buy for a Lifetime of Passive Income

Motley Fool

22 days ago

2 Dividend Stocks to Buy for a Lifetime of Passive Income

Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundup

Quartz

22 days ago

Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundup

Amgen (AMGN) Up 2.9% Since Last Earnings Report: Can It Continue?

Zacks

23 days ago

Amgen (AMGN) Up 2.9% Since Last Earnings Report: Can It Continue?

Amgen readies pivotal MariTide trials; Novo offers discounted Wegovy

BioPharma Dive

23 days ago

Amgen readies pivotal MariTide trials; Novo offers discounted Wegovy

2 Reasons to Watch AMGN and 1 to Stay Cautious

StockStory

23 days ago

2 Reasons to Watch AMGN and 1 to Stay Cautious

MT Newswires

24 days ago

Sector Update: Health Care Stocks Rise Late Afternoon

Amgen Inc. (AMGN): Among the Best Undervalued Stocks to Invest In Now

Insider Monkey

24 days ago

Amgen Inc. (AMGN): Among the Best Undervalued Stocks to Invest In Now

Johnson & Johnson and 4 Other Biopharmaceutical Stocks That Might Be Ready to Break Out

Barrons.com

24 days ago

Johnson & Johnson and 4 Other Biopharmaceutical Stocks That Might Be Ready to Break Out

MT Newswires

24 days ago

Sector Update: Health Care Stocks Higher in Afternoon Trading

Amgen just got one step closer to bringing its Ozempic competitor to market

Quartz

24 days ago

Amgen just got one step closer to bringing its Ozempic competitor to market

Amgen (NasdaqGS:AMGN) Declares US$2 Dividend Per Share For Q2 2025

Simply Wall St.

24 days ago

Amgen (NasdaqGS:AMGN) Declares US$2 Dividend Per Share For Q2 2025

MT Newswires

24 days ago

Amgen Launches Two Phase 3 Trials for Obesity Drug MariTide

With patent losses on the horizon, Amgen refocuses its business strategy

Pharma Voice

24 days ago

With patent losses on the horizon, Amgen refocuses its business strategy

AMGEN ANNOUNCES 2025 SECOND QUARTER DIVIDEND

PR Newswire

25 days ago

AMGEN ANNOUNCES 2025 SECOND QUARTER DIVIDEND

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know

Zacks

25 days ago

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Zacks

a month ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Amgen and AstraZeneca report results from Phase III trial of Tezspire for CRSwNP

Clinical Trials Arena

a month ago

Amgen and AstraZeneca report results from Phase III trial of Tezspire for CRSwNP

MT Newswires

a month ago

Astrazeneca-Amgen Asthma Treatment Reduces Nasal Polyps, Surgery Rates in Phase III Trial

POSITIVE RESULTS FROM TEZSPIRE® (TEZEPELUMAB-EKKO) PHASE 3 WAYPOINT TRIAL HIGHLIGHT RAPID, SUSTAINED EFFECT IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS

PR Newswire

a month ago

POSITIVE RESULTS FROM TEZSPIRE® (TEZEPELUMAB-EKKO) PHASE 3 WAYPOINT TRIAL HIGHLIGHT RAPID, SUSTAINED EFFECT IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS

Amgen Inc. (AMGN) Invests $200M in AI-Focused Tech Center in India, Plans to Hire 2,000 by 2025

Insider Monkey

a month ago

Amgen Inc. (AMGN) Invests $200M in AI-Focused Tech Center in India, Plans to Hire 2,000 by 2025

AMGEN TO PRESENT AT THE 45TH ANNUAL TD COWEN HEALTH CARE CONFERENCE

PR Newswire

a month ago

AMGEN TO PRESENT AT THE 45TH ANNUAL TD COWEN HEALTH CARE CONFERENCE

Why Amgen Inc. (AMGN) is the Best Vaccine Stock to Buy According to Hedge Funds?

Insider Monkey

a month ago

Why Amgen Inc. (AMGN) is the Best Vaccine Stock to Buy According to Hedge Funds?

This Could Be the Best GLP-1 Stock to Buy in 2025

Motley Fool

a month ago

This Could Be the Best GLP-1 Stock to Buy in 2025

Drug Stocks Are the New Safe Bet in a Shaky Market

The Wall Street Journal

a month ago

Drug Stocks Are the New Safe Bet in a Shaky Market

Amgen Inc: An Exploration into Its Intrinsic Value

GuruFocus.com

a month ago

Amgen Inc: An Exploration into Its Intrinsic Value

EXCLUSIVE: La La Anthony on Navigating Plaque Psoriasis, Her Partnership With Amgen and Moving Through Life ‘With More Confidence’

WWD

a month ago

EXCLUSIVE: La La Anthony on Navigating Plaque Psoriasis, Her Partnership With Amgen and Moving Through Life ‘With More Confidence’

Is Amgen Inc. (AMGN) the Best Retirement Stock to Buy According to Hedge Funds?

Insider Monkey

a month ago

Is Amgen Inc. (AMGN) the Best Retirement Stock to Buy According to Hedge Funds?

These 3 Dow Jones Stocks Are Crushing It in 2025. Are They Still Buys?

Motley Fool

a month ago

These 3 Dow Jones Stocks Are Crushing It in 2025. Are They Still Buys?

MT Newswires

a month ago

Sector Update: Health Care Stocks Advance Late Afternoon

MT Newswires

a month ago

Sector Update: Health Care Stocks Gain Monday Afternoon

MT Newswires

a month ago

Sector Update: Health Care

Is Amgen Inc. (AMGN) One of the Best Performing Dow Stocks So Far in 2025?

Insider Monkey

a month ago

Is Amgen Inc. (AMGN) One of the Best Performing Dow Stocks So Far in 2025?

5 Stocks in the Dow ETF That Survived the Worst Week Since October

Zacks

a month ago

5 Stocks in the Dow ETF That Survived the Worst Week Since October

MT Newswires

a month ago

Update: Market Chatter: Amgen to Invest $200 Million in India Site in 2025

MT Newswires

a month ago

Market Chatter: Amgen to Invest $200 Million in India Site in 2025

Argus Research

a month ago

Daily – Vickers Top Buyers & Sellers for 02/24/2025

MT Newswires

a month ago

Amgen Insider Sold Shares Worth $2,550,903, According to a Recent SEC Filing

The Zacks Analyst Blog Highlights AbbVie, Amgen, Stryker, Dexcom and Medtronic

Zacks

a month ago

The Zacks Analyst Blog Highlights AbbVie, Amgen, Stryker, Dexcom and Medtronic

MT Newswires

a month ago

Amgen Insider Sold Shares Worth $10,233,748, According to a Recent SEC Filing

Drugmaker Amgen to invest $200 million in India site, CEO says

Reuters

a month ago

Drugmaker Amgen to invest $200 million in India site, CEO says

Amgen Inc. (AMGN): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts

Insider Monkey

a month ago

Amgen Inc. (AMGN): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts

4 Seniors & Aging Demographics Stocks to Watch Right Now

Zacks

a month ago

4 Seniors & Aging Demographics Stocks to Watch Right Now

Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock

Zacks

a month ago

Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock

There May Be Some Bright Spots In Amgen's (NASDAQ:AMGN) Earnings

Simply Wall St.

a month ago

There May Be Some Bright Spots In Amgen's (NASDAQ:AMGN) Earnings

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Zacks

a month ago

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

MT Newswires

a month ago

Bernstein Adjusts Amgen Price Target to $350 From $380, Maintains Outperform Rating

MT Newswires

a month ago

Argus Cuts Price Target on Amgen to $330 From $360, Maintains Buy Rating

Argus Research

a month ago

Analyst Report: AMGEN Inc.

Argus Research

a month ago

Market Update: AMGN, KO, KR, KSS, ANET

Amgen Inc. (AMGN): A Bull Case Theory

Insider Monkey

a month ago

Amgen Inc. (AMGN): A Bull Case Theory

Amgen Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.

a month ago

Amgen Full Year 2024 Earnings: EPS Misses Expectations

Amgen Inc. (AMGN): Among the Best Drug Stocks to Buy Now

Insider Monkey

a month ago

Amgen Inc. (AMGN): Among the Best Drug Stocks to Buy Now

AMGEN TO PRESENT AT CITI'S 2025 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT

PR Newswire

a month ago

AMGEN TO PRESENT AT CITI'S 2025 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT

Moderna's Q4 loss: Can the pharma giant get to profitability?

Yahoo Finance Video

a month ago

Moderna's Q4 loss: Can the pharma giant get to profitability?

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Zacks

a month ago

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Argus Research

a month ago

Daily – Vickers Top Buyers & Sellers for 02/14/2025

MT Newswires

a month ago

Amgen Insider Sold Shares Worth $2,585,644, According to a Recent SEC Filing

MT Newswires

2 months ago

Amgen Insider Sold Shares Worth $7,341,123, According to a Recent SEC Filing

MT Newswires

2 months ago

Piper Sandler Adjusts Amgen Price Target to $329 From $310, Maintains Overweight Rating

Is Trending Stock Amgen Inc. (AMGN) a Buy Now?

Zacks

2 months ago

Is Trending Stock Amgen Inc. (AMGN) a Buy Now?

Investing $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move

Motley Fool

2 months ago

Investing $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move

3 Fabulous Dividend Stocks to Buy in February

Motley Fool

2 months ago

3 Fabulous Dividend Stocks to Buy in February

Don't Race Out To Buy Amgen Inc. (NASDAQ:AMGN) Just Because It's Going Ex-Dividend

Simply Wall St.

2 months ago

Don't Race Out To Buy Amgen Inc. (NASDAQ:AMGN) Just Because It's Going Ex-Dividend

Share on Social Networks: